By Talking Health TV –

Most of us know someone whose life has been changed or tragically cut short by prostate cancer, the most common cancer in men.

Every year, this disease claims the lives of 12,000 men in the UK, and alarmingly, one in four Black men will be diagnosed with it.

Despite the higher risk, the UK National Screening Committee (NSC) has not recommended routine screening for Black men, a decision that leaves thousands vulnerable and feels deeply personal to our communities.

Why Black Men Are Most at Risk

Prostate cancer can be treated successfully if detected early. Yet Black men are not only more likely to get the disease and die from it, but are often diagnosed at a later stage and less likely to receive guideline-recommended treatments.

Shockingly, even in less deprived areas, Black men die from prostate cancer at higher rates than white men in the most deprived areas, highlighting that this is not just about where people live; it’s a systemic health inequality.

This lack of early detection leaves lives to chance, feeding what many call a fatal postcode lottery.

Turning Frustration into Action

Prostate Cancer UK is challenging the government to take urgent, lifesaving action for Black men.

Campaigns are underway to empower GPs to start conversations about prostate cancer risk from age 45, potentially building the foundation for a future early detection program.

A ray of hope comes from the NSC’s recommendation to screen men with BRCA gene variations, the first time any screening for prostate cancer has been recommended.

It proves that with strong evidence, screening policies can change and lives can be saved.

The TRANSFORM Trial: A Game-Changer

The £42 million TRANSFORM trial is set to revolutionise early detection.

It is the most extensive study of its kind in 20 years and aims to include hundreds of thousands of men, with a focus on equitable participation for Black men who have historically been underrepresented in research.

Results will begin to roll in within two years, guiding future screening recommendations and helping save thousands of lives.

In parallel, Prostate Cancer UK has committed £4.6 million over five years to fight inequalities, including:

• £3.6 million for a Black Health Equity Strategy
• £1 million for real-world research projects to strengthen the evidence base

Deserving Better

The Black Equity Organisation (BEO), in partnership with Prostate Cancer UK, has voiced deep disappointment at the NSC decision.

The organisations stress that Black men face double the risk and twice the mortality rate from prostate cancer compared to their white counterparts.

Together, they are working to:

• Reduce late diagnosis
• Improve access to treatment
• Build stronger networks between Black community groups, the NHS, and researchers.

How You Can Help

You can support groundbreaking research and help save Black men’s lives by donating to the TRANSFORM trial: prostatecanceruk.org/donate.

Every contribution brings us closer to a world where no man dies from prostate cancer.